Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

Ti Titamax EX Impl Ti (4.1)3.75X9: medical device reports filed with FDA

337 reports name it, 2020–2026. Manufacturer given most often on reports: Jjgc. Product code DZE.

337
device reports naming the brand
0% of all MAUDE reports · about 55 a year
30
reports, 12 months to August 2026
26 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 337 reports that name the brand "Ti Titamax EX Impl Ti (4.1)3.75X9" (endosseous dental implant), received between May 2020 and August 2026; the manufacturer given most often on reports is Jjgc. Spellings of one product vary from report to report.

30 reports arrived in the 12 months to August 2026, up 15% from 26 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (68%), loss of osseointegration (27.9%) and fracture (1.5%). The patient problems coded most often are pain, fibrosis and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0713Sep 2021: 2Oct 2021: 1Nov 2021: 0Dec 2021: 32022Jan 2022: 11Feb 2022: 3Mar 2022: 4Apr 2022: 12May 2022: 4Jun 2022: 4Jul 2022: 5Aug 2022: 5Sep 2022: 7Oct 2022: 3Nov 2022: 5Dec 2022: 22023Jan 2023: 6Feb 2023: 1Mar 2023: 7Apr 2023: 5May 2023: 2Jun 2023: 9Jul 2023: 5Aug 2023: 9Sep 2023: 4Oct 2023: 6Nov 2023: 5Dec 2023: 02024Jan 2024: 2Feb 2024: 10Mar 2024: 6Apr 2024: 5May 2024: 6Jun 2024: 13Jul 2024: 7Aug 2024: 8Sep 2024: 1Oct 2024: 1Nov 2024: 6Dec 2024: 12025Jan 2025: 1Feb 2025: 2Mar 2025: 2Apr 2025: 3May 2025: 0Jun 2025: 4Jul 2025: 1Aug 2025: 4Sep 2025: 4Oct 2025: 6Nov 2025: 3Dec 2025: 32026Jan 2026: 4Feb 2026: 3Mar 2026: 0Apr 2026: 0May 2026: 3Jun 2026: 3Jul 2026: 0Aug 2026: 1

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

033662020: 5220202021: 4820212022: 6520222023: 5920232024: 6620242025: 3320252026: 142026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%337
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%337
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate22968%62.8%
Loss of osseointegration9427.9%22.4%
Fracturea broken bone51.5%1.6%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Painpain, site not specified8324.6%
Fibrosis3610.7%
Tissue damage3510.4%
Swelling/ edema319.2%
Fistula185.3%
Inflammationinflammation61.8%
Hemorrhage/blood loss/bleeding51.5%
Swellingswelling20.6%
Abscessa collection of pus10.3%
Hyperresponsive to stimuli10.3%
Numbnessnumbness10.3%
Sinus perforation10.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureTi Titamax EX Impl Ti (4.1)3.75X9Product code DZEAll MAUDE reports
Reports3373,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Ti Titamax EX Impl Ti (4.1)3.75X9 reports

How many FDA reports name Ti Titamax EX Impl Ti (4.1)3.75X9?

337 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 30 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (68%), loss of osseointegration (27.9%) and fracture (1.5%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Ti Titamax EX Impl Ti (4.1)3.75X9 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.